Dec 20 (Reuters) - IO Biotech Inc IOBT.O:
IO BIOTECH SECURES UP TO €57.5 MILLION IN DEBT FINANCING FROM THE EUROPEAN INVESTMENT BANK
FUNDS EXPECTED TO BE USED TO ADVANCE IO BIOTECH'S IMMUNE-MODULATING THERAPEUTIC CANCER VACCINES
DEBT FACILITY EXPECTED TO EXTEND COMPANY'S CASH RUNWAY INTO Q2 OF 2026
Source text: ID:nGNX4LFmBW
Further company coverage: IOBT.O
((Reuters.Briefs@thomsonreuters.com;))